Small bowel malignancies are rare neoplasms, usually inaccessible to conventional endoscopy but detectable in many cases by crosssectional imaging. Modern multidetector computed tomographies permit accurate diagnosis, complete pretreatment staging, and followup of these lesions. In this review, we describe the cross-sectional imaging features of the most frequent histologic subtypes of the small bowel malignancies.
Introduction
Small bowel neoplasms are uncommon and account for less than 5% of all gastrointestinal (GI) tract malignancies [1e4] . They are often associated with high mortality because tumour-related symptoms are often nonspecific and occur late in the clinical course. Typical clinical symptoms include partial or complete obstruction, weight loss, evidence of blood loss, and abdominal mass [1] . Less common symptoms include diarrhoea, weakness, fever, and pallor [1] . Because of their inaccessibility by conventional endoscopy, imaging plays an important role in diagnosis. Traditionally, barium studies have been considered the standard imaging test for neoplasms of the small bowel [1, 3] . More recently, multidetector computed tomography (MDCT) has shown increasing importance for detection, preoperative staging of tumour extension through the bowel wall, nodal involvement, and distant metastases, and for follow-up after treatment to detect recurrent or metastatic disease. In many cases, distinct morphologic features on cross-sectional imaging allow accurate prediction of tumour histology [3e14] . In this review, we present the cross-sectional imaging features of the most frequent histologic subtypes of malignant small bowel neoplasms.
Adenocarcinoma
The annual incidence of small bowel adenocarcinoma in the United States has been estimated to be 3.9 cases per million people, with peak age of presentation between 60 and 70 years [15] . Adenocarcinoma accounts for 30%-50% of all small bowel malignancies [16e18] . The majority of these neoplasms are located in the duodenum (54%), followed by the jejunum (28%), and the ileum (18%) [17, 18] . The higher incidence in the duodenum is thought to be related to the higher concentration of bile and its metabolites, which are implicated as possible carcinogens [17] . Like colon cancer, small bowel adenocarcinoma develops from an adenomatous polyp. Patients with small bowel adenocarcinoma have an elevated risk of developing large bowel adenocarcinomas, and vice versa [17] . Risk factors for small bowel adenocarcinoma include cigarette smoking, alcohol use, prior peptic ulcer disease, familial adenomatous polyposis, hereditary nonpolyposis colorectal cancer, celiac disease, and cystic fibrosis [15e18]. The risk of small bowel adenocarcinoma in familial adenomatous polyposis is estimated to be 50-300 times the general population [18] . Crohn disease also is an important risk factor [17, 18] . The risk for patients with Crohn disease is estimated to be 43-100 times greater than the average population [18] . Crohn associated adenocarcinomas tend to occur in the ileum, which reflects the distribution of disease [17] .
Patients with small bowel adenocarcinoma typically present in their 6th or 7th decade with obstruction, weight loss, anemia, rectal bleeding, and palpable mass [1] . Disease is more common in men than women [18] . Symptoms may be vague and result in delayed diagnosis, by which time tumours are often metastatic.
The accuracy of conventional computed tomography (CT) for diagnosis of small bowel tumours has been reported to be approximately 47% [16] . It is important to note that lesions smaller than 2 cm are frequently missed, especially by older single-slice CT technology that had neither the spatial nor temporal resolution of modern MDCT. The accuracy of modern MDCT for the diagnosis of small bowel adenocarcinoma has yet to be determined. CT is advantageous over conventional barium studies for detection of extramucosal spread, lymphadenopathy, and distant metastases [5] . CT features of adenocarcinoma are similar to those seen on barium studies and include short, sharply demarcated filling defect, eccentric thickening, or circumferential stenosis. Abrupt transition and irregular shouldered overhanging margins are typical [1, 5] . Obstruction is a common feature of small bowel adenocarcinoma [1] . Adenocarcinomas of the distal small bowel tend to be annular, whereas duodenal lesions tend to be papillary or polypoid [5] . After intravenous contrast administration, these mucosal-based soft-tissue lesions demonstrate enhancement ( Figure 1 ) [5] . Ulceration may be present in 40% of cases [1] . Large lesions may occasionally be mistaken for lymphoma; however, nodal metastases are less bulky in adenocarcinoma [2, 5, 6] . Metastases to regional lymph nodes and invasion of the mesenteric vessels occur relatively early and can present as stranding of the mesenteric fat, obliteration of fat planes, as well as nodular lesions greater than 4 mm in size ( Figure 1 ) [5] .
Carcinoid Tumour
Carcinoid tumours arise from argentaffin endocrine amine precursor uptake and decarboxylation Kulchitsky cells in the base of the crypts of Lieberk€ uhn, found throughout the GI tract and in other organs, such as the lung and pancreas [1, 7] . Carcinoid tumours represent approximately 2% of all GI tract malignancies and the second most common primary small bowel malignancy, with a predominance in woman [19, 20] . Whereas, most carcinoid tumours arise sporadically, syndromic carcinoid tumours are seen with type 1 and 2 multiple endocrine neoplasm (MEN) and type 1 neurofibromatosis [21] . They are also reported with increased frequency in hereditary nonpolyposis colorectal carcinoma [18] . Overall, GI tract carcinoid tumours occur most frequently in the appendix (50%). The small bowel is the next most common site (33%), most commonly in the ileum, followed by the jejunum [1, 8] .
Small intestinal carcinoid tumours are usually asymptomatic when small and confined to the bowel. Tumours become symptomatic when large enough to encroach upon the bowel lumen or when they metastasize to lymph nodes or the liver. Symptoms arise from both the local and systemic effects of these lesions. Local symptoms vary from vague to crampy abdominal pain, abdominal distension, nausea, vomiting, fatigue, and weight loss [1, 21] . The classic presentation of systemic carcinoid syndrome includes signs and symptoms of flushing of the face and neck, hypotension, tachycardia, secretory diarrhoea, telangiectasia, bronchial constriction, peptic ulceration, and right-sided cardiac lesions, and occurs in only 10% of patients. Systemic carcinoid syndrome may also be associated with bronchial carcinoids and tumours in other locations [1, 9] . Metastatic disease, predominantly to the liver, is found in 80% of patients with the syndrome [21] . The likelihood of metastases correlates to primary tumour size. Lesions smaller than 1 cm have nodal and liver metastases in fewer than 30% of patients. For tumours of 1-2 cm in size, this increases to 60%-80% for nodal metastases and 10% for liver metastases. Tumours larger than 2 cm have nodal metastases in 80% and liver metastases in 40%-50% [7] .
Radiologic findings depend upon the size and location of the tumour ( Figure 2 ). Small bowel series and fluoroscopic enteroclysis were used before the era of cross-sectional imaging [1, 9] . Modern MDCT scanners, which allow thinner collimation and faster scanning, can sometimes identify small tumours as avidly enhancing submucosal lesions. Detection is improved if water is given as an oral contrast and multiplanar reconstructions are performed. Low attenuation oral contrast permits optimal delineation of enhancing tumour against the bowel lumen. Dual-phase (arterial and venous) imaging allows optimal imaging of the arteries and veins. CT enteroclysis with multiplanar reconstruction has advantages of enteroclysis with morphologic imaging capabilities of helical CT, which lead to an improved detection rate. In a recent study, MDCT detected small bowel carcinoids with a sensitivity of 100% and specificity of 96.2% [9] . Whereas, CT may not always identify small tumours, it is excellent at demonstrating mesenteric extension and liver metastases. Carcinoid metastases to the liver are typically hypervascular on early arterial images, showing avid enhancement and becoming isoattenuating to the liver parenchyma on delayed phases [7] . Mesenteric metastases produce a well-defined soft-tissue mass with radiating linear densities that cause a stellate or spoke-wheel configuration. This is thought to occur secondary to fibrosis, with extension of tumour cells along neurovascular bundles ( Figure 2 ) [10] . The mesenteric vessels may be involved either directly because of encasement or narrowing, or indirectly because of the production of neuroendocrine chemicals and their effect on the vessel wall [7, 20] , and, when involved, fibrosis, ischemia, and oedema can occur, which results in a thickened bowel wall [21] . Calcifications occur in up to 70% of metastatic mesenteric masses. Conditions potentially confused with carcinoid include treated lymphoma and retractile mesenteritis [10] . Definitive diagnosis may not be possible before surgery for signs and symptoms of obstruction. Obstruction is usually not from the tumour itself but is secondary to mesenteric desmoplastic reaction and subsequent kinking of the bowel [11, 22, 23] .
Lymphoma
Non-Hodgkin lymphoma accounts for 1%-4% of GI tract malignancies [24] . Of these, 35%-50% involve the small bowel. Lymphomas originate from the lymphoid follicles of the submucosa [25] . The ileum is the most frequently affected, because of its abundance of lymphatic tissue. Lesions are frequently multiple (34%) and involve different segments (18%) or the same segment (16%) of the small bowel. More than 77% of lesions exceed 5 cm in diameter, and the average length of diseased bowel is 12 cm [2] .
The majority of GI lymphomas are of B-cell origin from mucosa-associated lymphoid tissue. Subtypes include immunoproliferative small intestinal disease (or Mediterranean type), mantle cell lymphoma, Burkitt lymphoma, follicular and lymphocytic lymphoma, and immunodeficiencyassociated lymphoma [26] . Mantle cell lymphoma is seen in adults older than 50 years, and mainly occurs in the terminal ileum and is characterized by numerous polypoid or masslike solid lesions. Burkitt lymphomas tend to occur in children at the ileocecal region. They are associated with the Epstein-Barr virus but also HIV/AIDS. Follicular and lymphocytic lymphomas also tend to occur in the ileocecal region. T-cell lymphomas are uncommon and are often associated with celiac disease. The jejunum is commonly involved and may demonstrate multiple ulcerated lesions [26] . Although primary GI tract lymphoma can present acutely because of perforation or obstruction, the presentation is often more insidious. Patients can present with abdominal pain, nausea and/or vomiting, anorexia, malaise, bleeding, anemia, diarrhoea, or constipation [1, 26, 27] .
Various morphologic forms have been described based on their cross-sectional findings (Figure 3 ). Lymphoma may present as a nodular filling defect, a polyp that may be the lead point of an intussusception, a long distensible infiltrating lesion with thickened walls with or without aneurysmal dilatation, or a large exoenteric mass that extends to the adjacent tissues [27, 28] . In most cases, small bowel lymphoma appears as a large, segmental nodular wall thickening. There is a gradual transition from bulky tumour to normal mucosa [6] . The bowel wall may often be asymmetrically thickened and can mimic adenocarcinoma. The main discriminating feature is the presence of bulky adenopathy in lymphoma ( Figure 3) [4, 6] . The next most common pattern is that of a polypoid lesion that may present as the lead point of an intussusception. Infiltrating lymphomas tend to produce ill-defined, thickened walls with irregular or complete loss of normal mucosal folds. The junction of tumour with normal mucosa is more gradual and difficult to define compared with adenocarcinoma. Obstruction is rare because the tumour weakens the muscularis propria, which results in dilatation [5] . This has been termed ''aneurysmal dilatation'' and is present in nearly 50% of cases [3] . Aneurysmal dilatation is caused by the infiltration of the muscularis propria and destruction of the autonomic nerve plexus by the lymphomatous cells, which cause the bowel to lose its tone and to dilate focally. The last pattern is that of a large exoenteric mass that extends beyond the bowel wall or serosal surface. This form may ulcerate and form fistulous tracts with adjacent loops of bowel [6] .
GI Stromal Tumour
GI stromal tumour (GIST) is the most common nonepithelial tumour of the GI tract and occurs most frequently in the stomach (60%) and small bowel (20%-30%) [29, 30] GIST includes many tumours previously designated as leiomyoma, cellular leiomyoma, leiomyoblastoma, and leiomyosarcoma [29] . GIST is believed to originate from the intestinal cells of Cajal or their stem-cell precursors [30] . Cajal cells are intermediates between the GI tract autonomic nervous system and smooth-muscle cells that regulate GI tract motility and autonomic nerve function. They are located around the myenteric plexus and in the muscularis propria throughout the GI tract [30] . Like the intestinal cells of Cajal from which they arise, the majority of GIST tumours stain positive at immunohistochemistry for vimentin and c-Kit (CD 117) [29] . The majority of GISTs can be classified as spindle cell type (70%), epithelioid type (20%), or mixed [29, 31, 32] .
GISTs are frequently discovered incidentally during imaging, surgery, or at autopsy [29] . The most common presentation of GIST is bleeding. Acute abdominal pain may arise from tumour rupture or obstruction, and mimic acute appendicitis (Figure 4) [30] . The peak age of onset is in the 6th decade [33] . At diagnosis, up to 30% of newly diagnosed GISTs are overtly malignant or demonstrate high malignant potential [30] . Syndromic GIST occurs in neurofibromatosis type 1 and familial GIST syndrome. In neurofibromatosis type 1, they tend to occur in the small intestine and are often multiple. With familial GIST, inheritance is autosomal dominant, and multiple diffuse GISTs develop. The Carney triad consists of gastric GIST, paraganglioma, pulmonary chondroma, or both [30] .
The radiographic features of GIST are similar to imaging features described previously for leiomyomas or leiomyosarcomas ( Figure 4) [1, 12] . GIST appears as a wellcircumscribed mass that compresses adjacent organs and lacks a true capsule [12, 13] . Because GIST involves the outer muscular layer of the bowel wall, there is a propensity for exophytic growth in 45%e86% [12, 13, 31] . GISTs can reach a large size, yet they rarely present with obstruction [12] . Mucosal ulceration is seen on the luminal surface in up to 50% of cases, and patients often present with GI tract bleeding [12, 13] .
On contrast-enhanced CT scans, peripheral enhancement is seen in large tumours. A central area of low attenuation usually corresponds to hemorrhage and/or necrosis. In some cases, the central area of low attenuation may represent the tumour itself, cystic degeneration, or fluid in an ulcer. Extensive necrosis and fistula formation may occur, which results in a cavitary mass (Figure 4 ). Lymphomas may also present with large ulcerated or cavitary masses, however, they tend to be associated with bulky lymphadenopathy [4, 6, 12] . Metastases are seen in up to 50% of GISTs and predominantly involve the liver and the peritoneum. When present, they tend to be hypervascular. Ascites is uncommon, because these tumours do not produce a significant inflammatory reaction [14] . Lymph node metastases and extraabdominal disease are seen in only advanced cases [33] .
Metastases to the Small Bowel
Overall, metastatic disease is the most common malignancy to involve the small bowel [6] . Hematogenous metastases most frequently arise from primary lesions of the lung, breast, kidneys, and skin (melanoma) [6] . Metastatic disease may also present as bulky mesenteric masses, which mimic lymphoma, or rarely, as focal bowel wall thickening, similar to adenocarcinoma. Clinical history assists to distinguish metastatic lesions from small bowel adenocarcinoma or lymphoma [6] . Melanoma is responsible for 25%-33% of intestinal metastases [2] . They often present as smooth, round-to-polypoid masses that cause transient intussusception rather than complete obstruction ( Figure 5 ) [34] . In the duodenum, target lesions with central ulceration may be seen. Lung metastases may be flat or polypoid and frequently ulcerate. Bowel metastases from breast cancer usually manifest as submucosal lesions in the duodenum [4] . Mucinous tumours of the ovary, appendix, and colon are the most common tumours to spread by intraperitoneal seeding [4] . Implants occur along the peritoneal linings, with a propensity to develop at the areas of relative fluid stasis, such as in the pouch of Douglas, ileocolic region, sigmoid mesocolon, and paracolic gutters [4] . On CT, peritoneal seeding appears as multifocal, discontinuous nodularity along the small bowel serosa, mesentery, and omentum; bowel-wall thickening; infiltration of the mesenteric or intraperitoneal fat; fixation; and kinking of bowel. Bowel obstruction is a frequent complication. Although mesenteric masses and stranding are nonspecific, history and clinical findings can distinguish metastatic disease from other entities [4] . Pancreatic, biliary, and colonic tumours may directly involve the small bowel by contiguous extension. CT is excellent in depicting extension of disease into adjacent organs and soft tissues [4] .
Summary
Malignancies of the small bowel are rare and are often discovered late in their clinical course. MDCT has recently become a powerful tool in the diagnosis of these lesions, which allows for diagnostic characterization of the lesion, prediction of histology, staging of regional and distant spread, and follow-up after treatment. A precise diagnosis can often be suggested from imaging alone as cross-sectional features correlate well with a histologic subtype. Because early diagnosis often provides the best hope for cure, when faced with unexplained GI tract blood loss, bowel obstruction, pain, weight loss, or other abdominal complaints for which a cause cannot be found, small bowel malignancies should be considered and investigated with MDCT. This will facilitate timely and effective management.
